Results 171 to 180 of about 53,742 (236)
Pregnancy, Volume 1, Issue 6, November 2025.Abstract The Society for Maternal‐Fetal Medicine collaborated with the American College of Obstetricians and Gynecologists and the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health to co‐sponsor the annual SMFM President's Workshop on preterm birth.
Society for Maternal‐Fetal Medicine (SMFM) +7 more
wiley +1 more source
CEB1: PHARMACOGENOMICS: EVALUATING THE ECONOMIC IMPACT
, 2000 DL Veenstra, MK Higashi
openalex +1 more source
Pharmacogenomics: road to anticancer therapeutics nirvana? [PDF]
, 2003 Apurva A. Desai +2 more
openalex +1 more source
FASEB BioAdvances, Volume 7, Issue 11, November 2025.iPSC Development and iPSC Application in ALS. ABSTRACT Since Yamanaka's landmark achievement in reprogramming somatic cells into induced pluripotent stem cells (iPSCs) using the four key transcription factors—OCT4, SOX2, KLF4, and c‐Myc (OSKM)—iPSC technology has made significant strides.
Yingliu Luo, Zhenru Xu, Zunxiong Li
wiley +1 more source
US FDA contemplates collection of pharmacogenomic data [PDF]
, 2003 Jim Kling
openalex +1 more source
British Journal of Pharmacology, Volume 182, Issue 21, Page 5340-5354, November 2025.Background and Purpose Chemotherapeutic treatment for colorectal cancer (colorectal cancer) allows for increased patient overall survival. However, current therapeutic regimens are often associated with the development of adverse drug reactions, which represent a morbidity, mortality and economic issue.
Ana Rita Simoes +20 more
wiley +1 more source
Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: gene resequencing and functional genomics [PDF]
, 2003 Araba A. Adjei +5 more
openalex +1 more source
Glycaemic responses to metformin monotherapy by SNP clusters in patients with type 2 diabetes
Diabetes, Obesity and Metabolism, Volume 27, Issue 11, Page 6323-6332, November 2025.Abstract Aims This study retrospectively investigates the association between polygenic risk scores (PRS) derived from SNP clusters and glycaemic response to metformin in patients with newly diagnosed T2D. Materials and Methods Utilizing a dataset from the Taiwan Precision Medicine Initiative, we evaluated alterations in fasting glucose (FBG) and ...
Wayne Huey‐Herng Sheu +10 more
wiley +1 more source
Pharmacogenomic Analysis of Mechanisms Mediating Ethanol Regulation of Dopamine β-Hydroxylase [PDF]
, 2003 Sajida Hassan +3 more
openalex +1 more source